Biotechne sec filings
WebAbout Us. Bio-Techne empowers researchers in Life Science and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services. Science is our passion; it drives us to collaborate, develop, and manufacture award-winning ... WebApr 11, 2024 · The firm owned 232,146 shares of the biotechnology company's stock after buying an additional 191,238 shares during the period. Natixis Advisors L.P. owned approximately 0.15% of Bio-Techne worth $19,240,000 as of its most recent filing with the Securities and Exchange Commission. Bio-Techne, J2 Global And InMode Break Out …
Biotechne sec filings
Did you know?
WebApr 14, 2024 · Bio-Techne Stock Up 2.9 %. TECH stock opened at $83.55 on Friday. The stock’s fifty day simple moving average is $74.91 and its two-hundred day simple moving average is $79.72. WebApr 12, 2024 · SEC filings and transcripts for Bio-Techne Corp, including financials, news, proxies, indentures, prospectuses, ... Letter from the SEC 02/16/23 CORRESP …
Web2 days ago · State of Michigan Retirement System boosted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Get Rating) by 301.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.The institutional investor owned 42,644 shares of the biotechnology company's stock after … WebAug 24, 2024 · The following information was filed by Biotechne Corp (TECH) on Thursday, August 4, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining …
WebJul 21, 2024 · Search SEC.gov. Company Filings. U.S. Securities and Exchange Commission WebJan 9, 2024 · All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR.
WebApr 10, 2024 · Berger Financial Group Inc raised its stake in Bio-Techne Co. (NASDAQ:TECH - Get Rating) by 300.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).The institutional investor owned 43,740 shares of the biotechnology company's stock after acquiring an additional …
WebApr 9, 2024 · BTC Capital Management Inc. grew its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Get Rating) by 297.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC.The fund owned 6,293 shares of the biotechnology company's stock after buying an additional 4,710 shares during the quarter. flock team communicationWebApr 12, 2024 · Daiwa Securities Group Inc. now owns 3,384 shares of the biotechnology company’s stock valued at $961,000 after buying an additional 38 shares during the period. greatland aquires jat softwareWebApr 14, 2024 · Shares of TECH opened at $83.55 on Friday. The firm has a 50-day moving average of $74.91 and a 200-day moving average of $79.72. Bio-Techne Co. has a one year low of $68.00 and a one year high of ... flock swimming ducks crosswordWebApr 14, 2024 · National Bank of Canada FI raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Get Rating) by 3,001.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.The fund owned 4,621 shares of the biotechnology company's stock after purchasing an additional 4,472 shares during … greatland associates anchorageWebApr 8, 2024 · Bank of Montreal Can raised its holdings in Bio-Techne Co. (NASDAQ:TECH - Get Rating) by 226.1% in the 4th quarter, according to its most recent 13F filing with the … flock theater amsterdamWebWebsite. bio-techne .com. Footnotes / references. [1] Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. The company's brands include R&D Systems, ProteinSimple, and Novus Biologicals. greatland backpackWebApr 8, 2024 · Bank of Montreal Can raised its holdings in Bio-Techne Co. (NASDAQ:TECH - Get Rating) by 226.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 172,808 shares of the biotechnology company's stock after acquiring an additional 119,810 shares during the period flock tender crossword